Injective (INJ) is currently trading at $3.32, reflecting a 24-hour change of -2.28%. The price has tested a daily high of $3.49 and a low at the same current price, indicating minimal volatility within the daily range of 0.17%.

The trading volume stands at approximately $49.94 million, contributing to a market cap volume ratio of 15.03%. Short-term moving averages indicate a bearish trend, with the 8 SMA at $3.35 (down 0.96%) and the 13 SMA at $3.37 (down 1.38%), suggesting that selling pressure persists in the immediate term.

The 1-hour RSI is at a critical 19, indicating that INJ is oversold in the short term, while the 7-day RSI at 58 reflects a neutral to slightly bullish sentiment. Notably, the 7-day and 14-day price changes of 10.56% and 18.47% respectively suggest a recent recovery phase after a prior downturn, but the momentum appears to be slowing down.

The 30-day price change shows a modest gain of 9.74%, which may reflect a broader upward trend in the medium term. However, the all-time high of $52.62 set in March 2024 emphasizes the significant distance the current price is from historical peaks, implying potential overvaluation at current levels.

Given the current price action, mixed short-term indicators, and the oversold condition indicated by the 1-hour RSI, a cautious approach is warranted. Therefore, the recommendation is to Hold, as the asset may rebound in the medium term but is vulnerable to continued short-term selling pressure.